{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:26Z","timestamp":1790957546996,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015027","name":"Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["950207475"],"award-info":[{"award-number":["950207475"]}],"id":[{"id":"10.13039\/501100015027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejphar.2023.175517","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:30:58Z","timestamp":1674037858000},"page":"175517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling"],"prefix":"10.1016","volume":"941","author":[{"given":"Shahla","family":"Eyvari Brooshghalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadmahdi","family":"Sabahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ahmad","family":"Ebadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mohajjel Nayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasool","family":"Haddadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175517_bib1","first-page":"59","article-title":"The effect of acute and repeated administration of buspirone, 8-OHDPAT and fluoxetine on haloperidol-induced extrapyramidal symptoms","volume":"21","author":"Ahmadi","year":"2019","journal-title":"Neuropsychopharmacol. Hungarica: Magyar Pszichofarmakol. Egyesulet Lapja Off. J. Hungar. Assoc. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2023.175517_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/excr.2000.4839","article-title":"The Bcl-2 protein family","volume":"256","author":"Antonsson","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2023.175517_bib3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/07391102.2015.1077343","article-title":"Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design","volume":"34","author":"Athar","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejphar.2023.175517_bib4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/08927022.2019.1662003","article-title":"Rutin as promising drug for the treatment of Parkinson's disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studies","volume":"45","author":"Azam","year":"2019","journal-title":"Mol. Simulat."},{"key":"10.1016\/j.ejphar.2023.175517_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neulet.2010.06.038","article-title":"Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress","volume":"480","author":"Baluchnejadmojarad","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175517_bib6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BST0351127","article-title":"Chronic microglial activation and progressive dopaminergic neurotoxicity","volume":"35","author":"Block","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2023.175517_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/1043-6618(92)91383-R","article-title":"Effect of the flavanolignans of< i> Silybum marianum<\/i> L. On lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes","volume":"25","author":"Bosisio","year":"1992","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2023.175517_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF\u03b1, and INF\u03b3 concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175517_bib9","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejphar.2023.175517_bib10","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","article-title":"Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice","volume":"25","author":"Choi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175517_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6\u2010OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175517_bib12","first-page":"321","article-title":"Microglia, an in vivo source of reactive oxygen species in the brain","volume":"59","author":"Colton","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.ejphar.2023.175517_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ph15010051","article-title":"Discovery of small molecules as membrane-bound catechol-O-methyltransferase inhibitors with interest in Parkinson's disease: pharmacophore modeling, molecular docking and in vitro experimental validation studies","volume":"15","author":"Cruz-Vicente","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2023.175517_bib14","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejphar.2023.175517_bib15","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1111\/ejn.15242","article-title":"Nuclear factor\u2010kappa B (NF\u2010\u03baB) in pathophysiology of Parkinson disease: diverse patterns and mechanisms contributing to neurodegeneration","volume":"54","author":"Dolatshahi","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175517_bib16","first-page":"405","article-title":"Ab-initio and conformational analysis of a potent VEGFR-2 inhibitor: a case study on motesanib","volume":"13","author":"Ebadi","year":"2014","journal-title":"IJPR"},{"key":"10.1016\/j.ejphar.2023.175517_bib17","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.175517_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pbb.2013.12.008","article-title":"Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats","volume":"117","author":"Geed","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2023.175517_bib19","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.3390\/molecules27092834","article-title":"Silico molecular docking analysis of karanjin against Alzheimer's and Parkinson's diseases as a potential natural lead molecule for new drug design, development and therapy","volume":"27","author":"Gnanaraj","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.175517_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2004.02527.x","article-title":"Neuronal expression of myeloperoxidase is increased in Alzheimer's disease","volume":"90","author":"Green","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2023.175517_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0944-7113(00)80017-3","article-title":"Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase","volume":"7","author":"Gupta","year":"2000","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2023.175517_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.15171\/apb.2015.063","article-title":"Short-term treatment with silymarin improved 6-OHDA-induced catalepsy and motor imbalance in hemi-parkisonian rats","volume":"5","author":"Haddadi","year":"2015","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.ejphar.2023.175517_bib23","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s00210-020-01954-7","article-title":"Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment","volume":"393","author":"Haddadi","year":"2020","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175517_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2013.09.022","article-title":"Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats","volume":"555","author":"Haddadi","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175517_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2013.09.022","article-title":"Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats","volume":"555","author":"Haddadi","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175517_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biopha.2018.05.020","article-title":"Silymarin prevents apoptosis through inhibiting the Bax\/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats","volume":"104","author":"Haddadi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2023.175517_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2008-2231-22-38","article-title":"Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study","volume":"22","author":"Haddadi","year":"2014","journal-title":"Daru"},{"key":"10.1016\/j.ejphar.2023.175517_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/2008-2231-22-38","article-title":"Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study","volume":"22","author":"Haddadi","year":"2014","journal-title":"Daru"},{"key":"10.1016\/j.ejphar.2023.175517_bib29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2023.175517_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejphar.2023.175517_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.phymed.2010.03.012","article-title":"Preventive effect of silymarin in cerebral ischemia\u2013reperfusion-induced brain injury in rats possibly through impairing NF-\u03baB and STAT-1 activation","volume":"17","author":"Hou","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2023.175517_bib32","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3390\/ijms11083016","article-title":"Advances and challenges in protein-ligand docking","volume":"11","author":"Huang","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175517_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejphar.2023.175517_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cbi.2013.09.016","article-title":"Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2\/Bax expression in experimental Parkinson's disease mice","volume":"206","author":"Kavitha","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2023.175517_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuroimage.2007.08.008","article-title":"Competition between functional brain networks mediates behavioral variability","volume":"39","author":"Kelly","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejphar.2023.175517_bib36","first-page":"490","article-title":"Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats","volume":"19","author":"Kheradmand","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.ejphar.2023.175517_bib37","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/jnr.22318","article-title":"Prothrombin kringle\u20102 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation","volume":"88","author":"Kim","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2023.175517_bib38","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175517_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejphar.2023.175517_bib40","first-page":"1","article-title":"Effects of the TLR4 signaling pathway on apoptosis of neuronal cells in diabetes mellitus complicated with cerebral infarction in a rat model","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.175517_bib41","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejphar.2023.175517_bib42","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.4049\/jimmunol.163.12.6800","article-title":"Silymarin suppresses TNF-induced activation of NF-\u03baB, c-Jun N-terminal kinase, and apoptosis","volume":"163","author":"Manna","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.175517_bib43","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA\u2010DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2023.175517_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175517_bib45","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2023.175517_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.brainresrev.2008.09.001","article-title":"Toll-like receptors in neurodegeneration","volume":"59","author":"Okun","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2023.175517_bib47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/08923970802278557","article-title":"Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson's-like disease","volume":"30","author":"Panaro","year":"2008","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2023.175517_bib48","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.ejphar.2023.175517_bib49","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.ejphar.2023.175517_bib50","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/ijms20071606","article-title":"Intestinal permeability study of clinically relevant formulations of silibinin in Caco-2 cell monolayers","volume":"20","author":"P\u00e9rez-S\u00e1nchez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175517_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2023.175517_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2011.07.035","article-title":"Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats","volume":"309","author":"Raza","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2023.175517_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2011.07.035","article-title":"Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats","volume":"309","author":"Raza","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2023.175517_bib54","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0002-9440(10)64779-7","article-title":"Mechanisms of apoptosis","volume":"157","author":"Reed","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2023.175517_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/exnr.1998.6977","article-title":"Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease","volume":"155","author":"Reynolds","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2023.175517_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-8993(00)03296-0","article-title":"Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence","volume":"892","author":"Roghani","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2023.175517_bib57","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.1017820108","article-title":"Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism","volume":"108","author":"Ros-Bernal","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2023.175517_bib58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.31857\/S0044467720040097","article-title":"The effect of chronic administration of buspirone, 8-ohdpat and different doses of fluoxetine on haloperidol induced extrapyramidal disorders and general locomotor activity in male rats","volume":"70","author":"Sabahi","year":"2020","journal-title":"\u0416\u0443\u0440\u043d\u0430\u043b \u0432\u044b\u0441\u0448\u0435\u0439 \u043d\u0435\u0440\u0432\u043d\u043e\u0439 \u0434\u0435\u044f\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u0438\u043c. \u0418\u041f \u041f\u0430\u0432\u043b\u043e\u0432\u0430"},{"key":"10.1016\/j.ejphar.2023.175517_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21859\/joqcr.3.1.1","article-title":"Effects of estrogen and progesterone on catalepsy and motor and balance impairment classified as haloperidol-induced extrapyramidal disorders","volume":"3","author":"Sabahi","year":"2018","journal-title":"J. Obstetr. Gynecol. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175517_bib60","first-page":"55","article-title":"The preventive\/protective effect of testosterone on haloperidol-induced extrapyramidal disorders in male rats","volume":"20","author":"Sabahi","year":"2018","journal-title":"J. Babol. Univ. Med. Sci."},{"key":"10.1016\/j.ejphar.2023.175517_bib61","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s12031-021-01818-6","article-title":"Modification of glial cell activation through dendritic cell vaccination: promises for treatment of neurodegenerative diseases","volume":"71","author":"Sabahi","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175517_bib62","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"\u0160ali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.175517_bib63","first-page":"229","article-title":"6 molecular mechanisms of pathogenesis of Parkinson's disease","volume":"281","author":"Shadrina","year":"2010","journal-title":"J. Pediatr. Matern. Fam. hEalth Chiroprac."},{"key":"10.1016\/j.ejphar.2023.175517_bib64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.15171\/apb.2015.067","article-title":"Effect of Buspirone, fluoxetine and 8-OH-DPAT on striatal expression of Bax, caspase-3 and Bcl-2 Proteins in 6-hydroxydopamine-induced hemi-parkinsonian rats","volume":"5","author":"Sharifi","year":"2015","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.ejphar.2023.175517_bib65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1874609810902020127","article-title":"Homology modeling of adenosine A2A receptor and molecular docking for exploration of appropriate potent antagonists for treatment of Parkinson's disease","volume":"2","author":"Singh","year":"2009","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.ejphar.2023.175517_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11010-013-1780-x","article-title":"Silymarin-and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism","volume":"384","author":"Singhal","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2023.175517_bib67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","article-title":"Melatonin or silymarin reduces maneb\u2010and paraquat\u2010induced Parkinson's disease phenotype in the mouse","volume":"50","author":"Singhal","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2023.175517_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2023.175517_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2000.7489","article-title":"Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease","volume":"166","author":"Tatton","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2023.175517_bib70","doi-asserted-by":"crossref","first-page":"W310","DOI":"10.1093\/nar\/gkl206","article-title":"GRAMM-X public web server for protein\u2013protein docking","volume":"34","author":"Tovchigrechko","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2023.175517_bib71","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuint.2010.09.005","article-title":"Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation","volume":"57","author":"Tsai","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2023.175517_bib72","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1046\/j.1460-9568.2002.02290.x","article-title":"Silymarin protects dopaminergic neurons against lipopolysaccharide\u2010induced neurotoxicity by inhibiting microglia activation","volume":"16","author":"Wang","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175517_bib73","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0006-2952(03)00535-5","article-title":"The essentiality of Bcl-2, PKC and proteasome\u2013ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline","volume":"66","author":"Youdim","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175517_bib74","series-title":"Computational Drug Design: a Guide for Computational and Medicinal Chemists","author":"Young","year":"2009"},{"key":"10.1016\/j.ejphar.2023.175517_bib75","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","article-title":"Apoptosis in the nervous system","volume":"407","author":"Yuan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.175517_bib76","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:14:58Z","timestamp":1757978098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":76,"alternative-id":["S0014299923000286"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175517","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175517"}}